ATC Group: A02BC03 Lansoprazole

Anatomical Therapeutic Chemical Classification System

Hierarchical position in ATC classification

Level
Code
Title
1
Alimentary tract and metabolism
2
Drugs for acid related disorders
3
DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)
4
Proton pump inhibitors
5
A02BC03
Lansoprazole

Active ingredients

Active Ingredient
Description

Lansoprazole is a gastric proton pump inhibitor. It inhibits the final stage of gastric acid formation by inhibiting the activity of H+/K+ ATPase of the parietal cells in the stomach. The inhibition is dose-dependent and reversible, and the effect applies to both basal and stimulated secretion of gastric acid.

Medicines in this ATC group

Drug
Countries

Austria Germany

South Africa

Tunisia

Hong Kong

South Africa

Lithuania

Hong Kong

South Africa

Brazil

Ireland New Zealand Spain

Australia

France Tunisia

Lithuania

Lithuania Poland

Singapore

France

Brazil

Tunisia

Canada Singapore United States

Netherlands

Hong Kong New Zealand

Hong Kong

Finland

Ireland

Australia

New Zealand

Australia Ireland Italy United Kingdom

Related product monographs

Title
Type
Country
Summary of Product Characteristics (SPC)
UK
Structured Product Labeling (SPL/PLR)
US
Summary of Product Characteristics (SPC)
UK